MedTrace Logo

Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch

NCT06724718 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 302

Last updated 2025-06-12

No results posted yet for this study

Summary

Postoperative atrial fibrillation (POAF) occurs in approximately 20% of patients following thoracic surgery. Early diagnosis is essential to prevent complications such as heart failure, stroke, myocardial infarction, and increased mortality. Smartwatches equipped with single-lead ECG capabilities and algorithms to detect asymptomatic atrial fibrillation (AF) offer a potential solution. This study aims to evaluate the effectiveness of smartwatches in detecting POAF compared to standard care.

Conditions

  • Postoperative Atrial Fibrillation
  • Thoracic Surgery
  • Smartwatches
  • Rhythm Monitoring
  • Cardiovascular Prognosis
  • Asymptomatic Atrial Fibrillation
  • Randomized Trial

Interventions

OTHER

smartwatch

Patients in the smartwatch group will undergo rhythm monitoring with a smartwatch

OTHER

ECG

Detected POAF episodes will be confirmed via a 12-lead ECG

Sponsors & Collaborators

  • Clinique Victor Pauchet

    collaborator OTHER

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Principal Investigators

  • Pierre Huette, MD · Centre Hospitalier Amiens

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2027-07-31
Completion
2027-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06724718 on ClinicalTrials.gov